Targeting the endocannabinoid system in cancer therapy: A call for further research

New uses warranted for cannabinoids? Recent data indicate that synthetic or endogenous substances activating the receptor for marijuana’s psychotropic component might be used as templates for the development of new anti-cancer drugs.